Skip to main content

Table 1 Mutation screening by next generation sequencing on tissue from hepatic metastasis∞

From: Malignant acrospiroma: a case report in the era of next generation sequencing

Gene

Percentage of expected sequencing coverage*

AKT1, BRAF, CDKN2A, DDR2, EGFR, ERBB2, HRAS, JAK2, KDR, KRAS, MAP2K1, NRAS, NTRK1, NTRK2, PIK3R1, PTPRD, TP53

100%

PIK3CA

96.9%

NOTCH1, NTRK3

96%

ALK

95%

PTEN

92.4%

PIK3R2

78.8%

  1. ∞ No mutations were identified
  2. *Percent of gene covered by a minimum of 100 sequence reads, as compared with expected coverage based on data from 10 normal DNA samples